Analysts Anticipate Surgery Partners Inc (NASDAQ:SGRY) to Post $0.07 Earnings Per Share

Equities analysts forecast that Surgery Partners Inc (NASDAQ:SGRY) will report earnings per share of $0.07 for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Surgery Partners’ earnings. The highest EPS estimate is $0.20 and the lowest is ($0.03). Surgery Partners reported earnings per share of ($0.74) during the same quarter last year, which would suggest a positive year over year growth rate of 109.5%. The company is expected to issue its next quarterly earnings report on Wednesday, March 11th.

According to Zacks, analysts expect that Surgery Partners will report full year earnings of ($0.91) per share for the current fiscal year, with EPS estimates ranging from ($1.02) to ($0.80). For the next year, analysts expect that the firm will report earnings of ($0.51) per share, with EPS estimates ranging from ($0.78) to ($0.24). Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.34) by $0.06. The firm had revenue of $452.00 million during the quarter, compared to analysts’ expectations of $452.30 million. Surgery Partners had a negative return on equity of 5.32% and a negative net margin of 11.26%. The company’s revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.19) earnings per share.

A number of brokerages have issued reports on SGRY. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Wednesday, October 9th. UBS Group upped their target price on Surgery Partners from $7.50 to $12.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 12th. BidaskClub raised Surgery Partners from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, November 12th. Finally, ValuEngine raised Surgery Partners from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and two have issued a strong buy rating to the company. Surgery Partners presently has an average rating of “Buy” and an average price target of $12.00.

Several hedge funds have recently modified their holdings of the company. Rhumbline Advisers lifted its holdings in shares of Surgery Partners by 8.7% during the third quarter. Rhumbline Advisers now owns 34,402 shares of the company’s stock worth $254,000 after buying an additional 2,763 shares during the last quarter. Alberta Investment Management Corp acquired a new position in shares of Surgery Partners during the third quarter worth approximately $328,000. Royal Bank of Canada lifted its holdings in shares of Surgery Partners by 64.3% during the second quarter. Royal Bank of Canada now owns 5,750 shares of the company’s stock worth $47,000 after buying an additional 2,250 shares during the last quarter. Citadel Advisors LLC lifted its holdings in shares of Surgery Partners by 17.4% during the second quarter. Citadel Advisors LLC now owns 544,948 shares of the company’s stock worth $4,436,000 after buying an additional 80,775 shares during the last quarter. Finally, Jefferies Group LLC lifted its holdings in shares of Surgery Partners by 22.4% during the second quarter. Jefferies Group LLC now owns 19,071 shares of the company’s stock worth $155,000 after buying an additional 3,490 shares during the last quarter. Institutional investors own 93.67% of the company’s stock.

Surgery Partners stock traded up $0.55 during trading hours on Thursday, reaching $11.99. 222,200 shares of the company were exchanged, compared to its average volume of 316,574. The firm has a market cap of $582.69 million, a price-to-earnings ratio of -4.89 and a beta of 2.35. The company has a current ratio of 1.36, a quick ratio of 1.24 and a debt-to-equity ratio of 2.39. The stock has a 50-day moving average of $8.71 and a 200 day moving average of $8.19. Surgery Partners has a 12 month low of $5.38 and a 12 month high of $14.69.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Featured Article: How to find the components of the quick ratio

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.